Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Revenue: 2021-2025

Historic Revenue for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $103.7 million.

  • Immunocore Holdings' Revenue rose 29.22% to $103.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $379.6 million, marking a year-over-year increase of 28.10%. This contributed to the annual value of $310.2 million for FY2024, which is 24.37% up from last year.
  • As of Q3 2025, Immunocore Holdings' Revenue stood at $103.7 million, which was up 5.85% from $98.0 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Revenue registered a high of $103.7 million during Q3 2025, and its lowest value of $8.9 million during Q4 2021.
  • For the 3-year period, Immunocore Holdings' Revenue averaged around $77.7 million, with its median value being $75.4 million (2024).
  • Data for Immunocore Holdings' Revenue shows a peak YoY soared of 33.16% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Immunocore Holdings' Revenue stood at $8.9 million in 2021, then reached $70.2 million in 2023, then rose by 19.80% to $84.1 million in 2024, then grew by 29.22% to $103.7 million in 2025.
  • Its Revenue was $103.7 million in Q3 2025, compared to $98.0 million in Q2 2025 and $93.9 million in Q1 2025.